Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination
A. Wagner, E. Garner-Spitzer, A. Schötta, M. Orola, A. Wessely, I. Zwazl, A. Ohradanova-Repic, G. Tajti, L. Gebetsberger, B. Kratzer, E. Tomosel, M. Kutschera, S. Tobudic, W. F. Pickl, M. Kundi, H. Stockinger, G. Novacek, W. Reinisch, C Zielinski, U. Wiedermann
doi: https://doi.org/10.1101/2021.12.13.21267603
A. Wagner
1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
E. Garner-Spitzer
1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
A. Schötta
2Institute for Hygiene and Applied Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
M. Orola
1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
A. Wessely
1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
I. Zwazl
1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
A. Ohradanova-Repic
2Institute for Hygiene and Applied Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
G. Tajti
2Institute for Hygiene and Applied Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
L. Gebetsberger
2Institute for Hygiene and Applied Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
B. Kratzer
3Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
E. Tomosel
1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
M. Kutschera
4Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University Vienna, Vienna, Austria
S. Tobudic
5Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
W. F. Pickl
3Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
M. Kundi
6Center for Public Health, Medical University Vienna, Vienna, Austria
H. Stockinger
2Institute for Hygiene and Applied Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
G. Novacek
4Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University Vienna, Vienna, Austria
W. Reinisch
4Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University Vienna, Vienna, Austria
C Zielinski
7Central European Cancer Center, Wiener Privatklinik, Vienna, Austria, and Central European Cooperative Oncology Group, HQ: Vienna, Austria
U. Wiedermann
1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
Article usage
Posted December 14, 2021.
Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination
A. Wagner, E. Garner-Spitzer, A. Schötta, M. Orola, A. Wessely, I. Zwazl, A. Ohradanova-Repic, G. Tajti, L. Gebetsberger, B. Kratzer, E. Tomosel, M. Kutschera, S. Tobudic, W. F. Pickl, M. Kundi, H. Stockinger, G. Novacek, W. Reinisch, C Zielinski, U. Wiedermann
medRxiv 2021.12.13.21267603; doi: https://doi.org/10.1101/2021.12.13.21267603
Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination
A. Wagner, E. Garner-Spitzer, A. Schötta, M. Orola, A. Wessely, I. Zwazl, A. Ohradanova-Repic, G. Tajti, L. Gebetsberger, B. Kratzer, E. Tomosel, M. Kutschera, S. Tobudic, W. F. Pickl, M. Kundi, H. Stockinger, G. Novacek, W. Reinisch, C Zielinski, U. Wiedermann
medRxiv 2021.12.13.21267603; doi: https://doi.org/10.1101/2021.12.13.21267603
Subject Area
Subject Areas
- Addiction Medicine (396)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12687)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4546)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2901)
- Health Policy (1067)
- Hematology (383)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4313)
- Nursing (233)
- Nutrition (633)
- Oncology (2253)
- Ophthalmology (641)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1193)
- Primary Care Research (492)
- Public and Global Health (6901)
- Radiology and Imaging (1519)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)